New Product
신제품.
- Home
- 신제품/베스트
- 신제품
New Biosimilar 제품 리스트
2025-09-30
New Biosimilar 제품 리스트
| Biosimilar | |
| Catalog No. | Product name |
| DHB95501 | Research Grade Bermekimab |
| DHB95602 | Research Grade Gevokizumab |
| DHC13501 | Research Grade Pascolizumab |
| DHC15802 | Research Grade Ziltivekimab |
| DHC15803 | Research Grade Sirukumab |
| DHC15804 | Research Grade Olokizumab |
| DHC15805 | Research Grade Clazakizumab |
| DHD09601 | Research Grade Enokizumab |
| DHD84002 | Research Grade Briakinumab |
| DHE07701 | Research Grade Cendakimab |
| DHE07702 | Research Grade Lebrikizumab |
| DHE07703 | Research Grade Tralokinumab |
| DHE07706 | Research Grade Anrukinzumab |
| DHE07707 | Research Grade Dectrekumab |
| DHH28803 | Research Grade Bimekizumab |
| DHH28804 | Research Grade Vunakizumab |
| DHH28805 | Research Grade Netakimab |
| DHH28806 | Research Grade Perakizumab |
| DHH28807 | Research Grade Afasevikumab |
| DHJ69101 | Research Grade Fletikumab |
| DHJ59401 | Research Grade Avizakimab |
| DHJ53501 | Research Grade Fezakinumab |
| DHJ63104 | Research Grade Brazikumab |
| DHJ63105 | Research Grade Mirikizumab |
| DHB74001 | Research Grade Etokimab |
| DHB74002 | Research Grade Itepekimab |
| DHB94501 | Research Grade Sifalimumab |
| DHB94502 | Research Grade Faralimomab |
| DHB94503 | Research Grade Rontalizumab |
| DHB95402 | Research Grade Fontolizumab |
| DHB94406 | Research Grade Nerelimomab |
| DHB91601 | Research Grade Fresolimumab |
| DHB91602 | Research Grade Metelimumab |
| DHF46301 | Research Grade Lerdelimumab |
| DHC12001 | Research Grade Xentuzumab |
| DHC12002 | Research Grade Dusigitumab |
| DHD12604 | Research Grade Varisacumab |
| DHB91701 | Research Grade Tanezumab |
| DHB91702 | Research Grade Fasinumab |
| DHB91703 | Research Grade Fulranumab |
| DFB91701 | Research Grade Frunevetmab |
| DHD03701 | Research Grade Ficlatuzumab |
| DHD03702 | Research Grade Rilotumumab |
| DHD82301 | Research Grade Pamrevlumab |
| DHC42101 | Research Grade Lacnotuzumab |
| DHC06701 | Research Grade Namilumab |
| DHC06702 | Research Grade Otilimab |
| DHC06703 | Research Grade Lenzilumab |
| DHC06704 | Research Grade Gimsilumab |
| DHC97801 | Research Grade Carlumab |
| DHE85001 | Research Grade Bertilimumab |
| DHF68001 | Research Grade Quetmolimab |
| DHC01901 | Research Grade Eldelumab |
| DHB94301 | Research Grade Pateclizumab |
| DHJ36101 | Research Grade Tezepelumab |
| DHJ72801 | Research Grade Spesolimab |
| DHC20801 | Research Grade Siplizumab |
| DHC27701 | Research Grade Muromonab |
| DHC27702 | Research Grade Otelixizumab |
| DHC27703 | Research Grade Teplizumab |
| DHC27704 | Research Grade Visilizumab |
| DHC27705 | Research Grade Foralumab |
| DHB95902 | Research Grade Zanolimumab |
| DHB95903 | Research Grade Tregalizumab |
| DHB95904 | Research Grade Cedelizumab |
| DHB95905 | Research Grade Clenoliximab |
| DHB95906 | Research Grade Keliximab |
| DHC18801 | Research Grade Zolimomab |
| DHD87601 | Research Grade Itolizumab |
| DHD41002 | Research Grade Odulimomab |
| DHC33701 | Research Grade Atibuclimab |
| DHC13101 | Research Grade Erlizumab |
| DHD10801 | Research Grade Coltuximab |
| DHD10805 | Research Grade Denintuzumab |
| DHD10807 | Research Grade Obexelimab |
| DHC90706 | Research Grade Ublituximab |
| DHC90707 | Research Grade Ripertamab |
| DHC90709 | Research Grade Tositumomab |
| DHC90711 | Research Grade Veltuzumab |
| DHC90712 | Research Grade Ocaratuzumab |
| DHD38503 | Research Grade Epratuzumab |
| DHD38505 | Research Grade Anti-Human CD22 Antibody (Immurait-Ll2Mab) |
| DHD38506 | Research Grade Pinatuzumab |
| DHC21301 | Research Grade Lumiliximab |
| DHB95804 | Research Grade Inolimomab |
| DHD74101 | Research Grade Begelomab |
| DHD72201 | Research Grade Varlilumab |
| DHC83401 | Research Grade Lulizumab |
| DHD80902 | Research Grade Iratumumab |
| DHD37502 | Research Grade Lintuzumab |
| DHD37503 | Research Grade Vadastuximab |
| DHC85102 | Research Grade Naratuximab |
| DHD80803 | Research Grade Mezagitamab |
| DHD80804 | Research Grade Felzartamab |
| DHD68901 | Research Grade Iscalimab |
| DHD68902 | Research Grade Bleselumab |
| DHD68903 | Research Grade Selicrelumab |
| DHD68904 | Research Grade Giloralimab |
| DHD68905 | Research Grade Lucatumumab |
| DHD68906 | Research Grade Mitazalimab |
| DHD68907 | Research Grade Vanalimab |
| DHD68908 | Research Grade Dacetuzumab |
| DHD68909 | Research Grade Teneliximab |
| DHD68910 | Research Grade Ravagalimab |
| DHC33303 | Research Grade Tadocizumab |
| DHD14801 | Research Grade Bivatuzumab |
| DHC34001 | Research Grade Apamistamab |
| DHG17602 | Research Grade Urabrelimab |
| DHD23401 | Research Grade Vatelizumab |
| DHC98803 | Research Grade Etrolizumab |
| DHC98804 | Research Grade Abrilumab |
| DHC35101 | Research Grade Volociximab |
| DHC21901 | Research Grade Abituzumab |
| DHC21902 | Research Grade Etaracizumab |
| DHC21903 | Research Grade Intetumumab |
| DHD95102 | Research Grade Gatralimab |
| DHC16001 | Research Grade Bersanlimab |
| DHC16002 | Research Grade Enlimomab |
| DHC98501 | Research Grade Lorvotuzumab |
| DHD03301 | Research Grade Aselizumab |
| DHD15102 | Research Grade Inclacumab |
| DHE25601 | Research Grade Tinurilimab |
| DHC21001 | Research Grade Labetuzumab |
| DHC21004 | Research Grade Altumomab |
| DHE01901 | Research Grade Cusatuzumab |
| DHE01902 | Research Grade Vorsetuzumab |
| DHD46601 | Research Grade Oleclumab |
| DHC08001 | Research Grade Milatuzumab |
| DHE26302 | Research Grade Iladatuzumab |
| DHE03401 | Research Grade Galiximab |
| DHD47201 | Research Grade Avdoralimab |
| DHJ33901 | Research Grade Pepinemab |
| DHD26501 | Research Grade Carotuximab |
| DHC25201 | Research Grade Cabiralizumab |
| DHC25202 | Research Grade Emactuzumab |
| DHC25203 | Research Grade Axatilimab |
| DHD11501 | Research Grade Mavrilimumab |
| DHD72501 | Research Grade Talacotuzumab |
| DHC36903 | Research Grade Levilimab |
| DHE43201 | Research Grade Ivuxolimab |
| DHE43202 | Research Grade Pogalizumab |
| DHE43203 | Research Grade Tavolimab |
| DHE43204 | Research Grade Cudarolimab |
| DHE43205 | Research Grade Revdofilimab |
| DHE43206 | Research Grade Telazorlimab |
| DHG03401 | Research Grade Narnatumab |
| DHG11002 | Research Grade Urelumab |
| DHG11001 | Research Grade Utomilumab |
| DHD30801 | Research Grade Indatuximab |
| DHD16102 | Research Grade Tovetumab |
| DHC42201 | Research Grade Rinucumab |
| DHD00601 | Research Grade Tisotumab |
| DHE39701 | Research Grade Imaprelimab |
| DHE14001 | Research Grade Meplazumab |
| DHD17202 | Research Grade Zalifrelimab |
| DHD17203 | Research Grade Tremelimumab |
| DHD17204 | Research Grade Ticilimumab |
| DHD17205 | Research Grade Nurulimab |
| DHD85403 | Research Grade Ruplizumab |
| DHE43401 | Research Grade Lirilumab |
| DHE43801 | Research Grade Lacutamab |
| DHD71901 | Research Grade Monalizumab |
| DHG64001 | Research Grade Praluzatamab |
| DHF39901 | Research Grade Ulocuplumab |
| DHE33201 | Research Grade Plozalizumab |
| DHE85401 | Research Grade Leronlimab |
| DHE30301 | Research Grade Samalizumab |
| DHC29902 | Research Grade Ganitumab |
| DHC29904 | Research Grade Cixutumumab |
| DHC29905 | Research Grade Figitumumab |
| DHD30401 | Research Grade Ieramilimab |
| DHD30403 | Research Grade Relatlimab |
| DHD30404 | Research Grade Encelimab |
| DHD30405 | Research Grade Fianlimab |
| DHD30406 | Research Grade Miptenalimab |
| DHD14201 | Research Grade Gatipotuzumab |
| DHD14202 | Research Grade Sontuzumab |
| DHD14205 | Research Grade Clivatuzumab |
| DHD14207 | Research Grade Pankomab |
| DHF92103 | Research Grade Roledumab |
| DHJ61001 | Research Grade Ontuxizumab |
| DHD58801 | Research Grade Oxelumab |
| DHJ85302 | Research Grade Tabalumab |
| DHA05901 | Research Grade Mapatumumab |
| DHA29101 | Research Grade Benufutamab |
| DHA29102 | Research Grade Tigatuzumab |
| DHA29103 | Research Grade Conatumumab |
| DHA29104 | Research Grade Drozitumab |
| DHA29105 | Research Grade Lexatumumab |
| DHA29106 | Research Grade Tilogotamab |
| DHJ62201 | Research Grade Enavatuzumab |
| DHJ42201 | Research Grade Ianalumab |
| DHJ14401 | Research Grade Tifcemalimab |
| DHJ70105 | Research Grade Pacmilimab |
| DHJ70106 | Research Grade Cosibelimab |
| DHJ70107 | Research Grade Manelimab |
| DHJ70108 | Research Grade Adebrelimab |
| DHJ70109 | Research Grade Opucolimab |
| DHB10201 | Research Grade Prezalumab |
| DHJ04001 | Research Grade Enoblituzumab |
| DHJ04002 | Research Grade Omburtamab |
| DHJ04003 | Research Grade Mirzotamab |
| DHJ92101 | Research Grade Vopratelimab |
| DHJ92102 | Research Grade Feladilimab |
| DHH02203 | Research Grade Balstilimab |
| DHH02204 | Research Grade Cetrelimab |
| DHH02206 | Research Grade Tislelizumab |
| DHH02207 | Research Grade Sintilimab |
| DHH02208 | Research Grade Toripalimab |
| DHH02210 | Research Grade Budigalimab |
| DHH02211 | Research Grade Camrelizumab |
| DHH02212 | Research Grade Lodapolimab |
| DHH02213 | Research Grade Serplulimab |
| DHH02214 | Research Grade Spartalizumab |
| DHH02217 | Research Grade Prolgolimab |
| DHH02218 | Research Grade Retifanlimab |
| DHH02219 | Research Grade Sasanlimab |
| DHH02220 | Research Grade Ezabenlimab |
| DHA95501 | Research Grade Tomaralimab |
| DHA30101 | Research Grade Vesencumab |
| DHE16602 | Research Grade Olinvacimab |
| DHE16605 | Research Grade Vulinacimab |
| DHD72101 | Research Grade Tesnatilimab |
| DHJ64002 | Research Grade Azintuxizumab |
| DHD17401 | Research Grade Citatuzumab |
| DHD17403 | Research Grade Edrecolomab |
| DHD47901 | Research Grade Bemarituzumab |
| DHD47902 | Research Grade Aprutumab |
| DHD52901 | Research Grade Vofatamab |
| DHC09603 | Research Grade Disitamab |
| DHC09605 | Research Grade Timigutuzumab |
| DHJ94801 | Research Grade Tabituximab |
| DHJ89801 | Research Grade Ragifilimab |
| DHJ28401 | Research Grade Cobolimab |
| DHJ28402 | Research Grade Sabatolimab |
| DHF88301 | Research Grade Astegolimab |
| DHJ26601 | Research Grade Nemolizumab |
| DHD23001 | Research Grade Anifrolumab |
| DHB86904 | Research Grade Modotuximab |
| DHB86905 | Research Grade Tomuzotuximab |
| DHB86908 | Research Grade Depatuxizumab |
| DHB86909 | Research Grade Demupitamab |
| DHB86910 | Research Grade Zatuximab |
| DHB86912 | Research Grade Laprituximab |
| DHB86913 | Research Grade Losatuxizumab |
| DHB86914 | Research Grade Nimotuzumab |
| DHB86915 | Research Grade Serclutamab |
| DHB86916 | Research Grade Zalutumumab |
| DHJ92702 | Research Grade Ligelizumab |
| DHJ92703 | Research Grade Talizumab |
| DHJ92704 | Research Grade Quilizumab |
| DHC43601 | Research Grade Sutimlimab |
| DHB90003 | Research Grade Olendalizumab |
| DHB90004 | Research Grade Tesidolumab |
| DHB90005 | Research Grade Crovalimab |
| DHB90006 | Research Grade Pozelimab |
| DHB90008 | Research Grade Vilobelimab |
| DHC04201 | Research Grade Osocimab |
| DHC04202 | Research Grade Abelacimab |
| DHB88201 | Research Grade Garadacimab |
| DHC82801 | Research Grade Befovacimab |
| DHC82802 | Research Grade Concizumab |
| DHC82803 | Research Grade Marstacimab |
| DHC12501 | Research Grade Crenezumab |
| DHC12502 | Research Grade Donanemab |
| DHC12503 | Research Grade Gantenerumab |
| DHC12504 | Research Grade Aducanumab |
| DHC12505 | Research Grade Solanezumab |
| DHC12506 | Research Grade Lecanemab |
| DHC12507 | Research Grade Bapineuzumab |
| DHK08301 | Research Grade Ponezumab |
| DHC82401 | Research Grade Gosuranemab |
| DHC82402 | Research Grade Zagotenemab |
| DHC82403 | Research Grade Tilavonemab |
| DHC82404 | Research Grade Semorinemab |
| DHC82405 | Research Grade Bepranemab |
| DHE22001 | Research Grade Cinpanemab |
| DHE22002 | Research Grade Prasinezumab |
| DHJ57402 | Research Grade Tamrintamab |
| DHH37201 | Research Grade Girentuximab |
| DHD06801 | Research Grade Andecaliximab |
| DHD48401 | Research Grade Elgemtumab |
| DHD48402 | Research Grade Lumretuzumab |
| DHD48403 | Research Grade Duligotuzumab |
| DHD48404 | Research Grade Patritumab |
| DHD48405 | Research Grade Seribantumab |
| DHH72401 | Research Grade Tiragolumab |
| DHH72402 | Research Grade Etigilimab |
| DHJ24003 | Research Grade Frovocimab |
| DHJ24004 | Research Grade Bococizumab |
| DHJ24005 | Research Grade Lodelcizumab |
| DHJ24006 | Research Grade Ralpancizumab |
| DHJ24007 | Research Grade Tafolecimab |
| DHJ24008 | Research Grade Ongericimab |
| DHA30601 | Research Grade Landogrozumab |
| DHA30602 | Research Grade Trevogrumab |
| DHA30603 | Research Grade Domagrozumab |
| DHA30604 | Research Grade Stamulumab |
| DHC34201 | Research Grade Emibetuzumab |
| DHC34203 | Research Grade Telisotuzumab |
| DHH39201 | Research Grade Timolumab |
| DHJ31001 | Research Grade Abagovomab |
| DHJ31003 | Research Grade Oregovomab |
| DHJ31004 | Research Grade Sofituzumab |
| DHJ65301 | Research Grade Demcizumab |
| DHJ65302 | Research Grade Enoticumab |
| DHD10401 | Research Grade Farletuzumab |
| DHD10402 | Research Grade Mirvetuximab |
| DHD65601 | Research Grade Indusatumab |
| DHF14601 | Research Grade Orilanolimab |
| DHF14602 | Research Grade Rozanolixizumab |
| DHF14603 | Research Grade Batoclimab |
| DHF14604 | Research Grade Nipocalimab |
| DHJ48702 | Research Grade Blosozumab |
| DHJ48703 | Research Grade Setrusumab |
| DHE51801 | Research Grade Volagidemab |
| DHE51802 | Research Grade Crotedumab |
| DHG52001 | Research Grade Anetumab |
| DHG52002 | Research Grade Amatuximab |
| DHK06701 | Research Grade Ozanezumab |
| DHK06702 | Research Grade Atinumab |
| DHD89501 | Research Grade Enapotamab |
| DHD89502 | Research Grade Tilvestamab |
| DHG01304 | Research Grade Rosopatamab |
| DHC00101 | Research Grade Dezamizumab |
| DHJ37701 | Research Grade Elezanumab |
| DHF78601 | Research Grade Ensituximab |
| DHD25201 | Research Grade Flanvotumab |
| DHC33101 | Research Grade Garetosmab |
| DHG93101 | Research Grade Glembatumumab |
| DHD27401 | Research Grade Icrucumab |
| DHD82501 | Research Grade Ifabotuzumab |
| DHD03401 | Research Grade Imalumab |
| DHB65401 | Research Grade Lifastuzumab |
| DHB65402 | Research Grade Upifitamab |
| DHG52901 | Research Grade Ladiratuzumab |
| DHB60001 | Research Grade Lupartumab |
| DHH34701 | Research Grade Murlentamab |
| DHA04501 | Research Grade Narsoplimab |
| DHA42303 | Research Grade Nesvacumab |
| DHJ63401 | Research Grade Nadunolimab |
| DHD46201 | Research Grade Nimacimab |
| DHG54901 | Research Grade Ontamalimab |
| DHK06901 | Research Grade Onvatilimab |
| DHJ39101 | Research Grade Opicinumab |
| DHJ76201 | Research Grade Parsatuzumab |
| DHC01501 | Research Grade Tacatuzumab |
| DHC65501 | Research Grade Birtamimab |
| DHD43401 | Research Grade Refanezumab |
| DHJ51101 | Research Grade Rosmantuzumab |
| DHD18001 | Research Grade Rolinsatamab |
| DHK06401 | Research Grade Rovalpituzumab |
| DHC43302 | Research Grade Datopotamab |
| DHJ28801 | Research Grade Samrotamab |
| DHG32201 | Research Grade Sibrotuzumab |
| DHK06601 | Research Grade Simtuzumab |
| DHK06801 | Research Grade Sirtratumab |
| DHE48301 | Research Grade Brontictuzumab |
| DHG01801 | Research Grade Tarextumab |
| DHJ76001 | Research Grade Vandortuzumab |
| DHJ82501 | Research Grade Vantictumab |
| DHD49201 | Research Grade Zampilimab |
| DHE32801 | Research Grade Zelminemab |
| DHF19801 | Research Grade Zolbetuximab |
| DHB96801 | Research Grade Apolizumab |
| DHE20501 | Research Grade Ascrinvacumab |
| DHD72801 | Research Grade Bimagrumab |
| DHE84601 | Research Grade Codrituzumab |
| DHG47801 | Research Grade Cofetuzumab |
| DHK10001 | Research Grade Satumomab |
| DHK10002 | Research Grade Minretumomab |
| DHK09901 | Research Grade Orticumab |
| DHK09001 | Research Grade Bexmarilimab |
| DHJ14801 | Research Grade Alsevalimab |
| DHC35301 | Research Grade Pritumumab |
| DGK11301 | Research Grade Ecromeximab |
| DGK11201 | Research Grade Racotumomab |
| DGK10101 | Research Grade Bavituximab |
| DGX03201 | Research Grade Pagibaximab |
| DXX00101 | Research Grade Tosatoxumab |
| DXX00102 | Research Grade Suvratoxumab |
| DXX00103 | Research Grade Atidortoxumab |
| DXX00801 | Research Grade Berlimatoxumab |
| DXX04801 | Research Grade Tefibazumab |
| DXX00601 | Research Grade Pritoxaximab |
| DXX00501 | Research Grade Urtoxazumab |
| DXX00701 | Research Grade Setoxaximab |
| DVV00302 | Research Grade Cilgavimab |
| DVV00303 | Research Grade Bamlanivimab |
| DVV00304 | Research Grade Casirivimab |
| DVV00305 | Research Grade Imdevimab |
| DVV00306 | Research Grade Etesevimab |
| DVV00307 | Research Grade Sotrovimab |
| DVV05101 | Research Grade Sevirumab |
| DVV02901 | Research Grade Regavirumab |
| DVV03002 | Research Grade Exbivirumab |
| DVV03003 | Research Grade Libivirumab |
| DVV03701 | Research Grade Lenvervimab |
| DVV03101 | Research Grade Suvizumab |
| DVV03102 | Research Grade Elipovimab |
| DVV03801 | Research Grade Diridavumab |
| DVV03802 | Research Grade Firivumab |
| DVV03804 | Research Grade Gedivumab |
| DVV02802 | Research Grade Nirsevimab |
| DVV02803 | Research Grade Motavizumab |
| DVV02807 | Research Grade Suptavumab |
| DVV03901 | Research Grade Foravirumab |
| DVV03902 | Research Grade Rafivirumab |
| DVV03501 | Research Grade Docaravimab |
| DVV03502 | Research Grade Miromavimab |
| DVV03601 | Research Grade Larcaviximab |
| DVV03603 | Research Grade Cosfroviximab |
| DHC79101 | Research Grade Anti-Human IL8/CXCL8 Antibody (HuMax-IL8) |
| DHC79102 | Research Grade Anti-Human IL8/CXCL8 Antibody (ABX-IL8) |
| DHE28301 | Research Grade Anti-Human IL15 Antibody (HuMax-IL15) |
| DHD99901 | Research Grade Anti-Human CD185/CXCR5 Antibody (SAR113244) |
| DHJ70112 | Research Grade Anti-Human CD274/PD-L1/B7-H1 Antibody (BMS-936559/MDX-1105) |
| DHG01303 | Research Grade Capromab |
| DHB95802 | Research Grade Basiliximab |
| DHB95801 | Research Grade Daclizumab |
| DVV02801 | Research Grade Palivizumab |
| DHD37501 | Research Grade Gemtuzumab |
| DHD95101 | Research Grade Alemtuzumab |
| DHC90703 | Research Grade Ibritumomab |
| DHJ92701 | Research Grade Omalizumab |
| DHD12602 | Research Grade Bevacizumab |
| DHC98801 | Research Grade Natalizumab |
| DHB86903 | Research Grade Panitumumab |
| DHB95601 | Research Grade Canakinumab |
| DHB94404 | Research Grade Golimumab |
| DHC90701 | Research Grade Ofatumumab |
| DHD84001 | Research Grade Ustekinumab |
| DHA30301 | Research Grade Denosumab |
| DHC36902 | Research Grade Tocilizumab |
| DHJ85301 | Research Grade Belimumab |
| DHD80901 | Research Grade Brentuximab |
| DHD17201 | Research Grade Ipilimumab |
| DHC09602 | Research Grade Pertuzumab |
| DXX00402 | Research Grade Raxibacumab |
| DHC90704 | Research Grade Obinutuzumab |
| DHE16601 | Research Grade Ramucirumab |
| DHC15801 | Research Grade Siltuximab |
| DHC98802 | Research Grade Vedolizumab |
| DHJ24001 | Research Grade Alirocumab |
| DHD80801 | Research Grade Daratumumab |
| DGK07801 | Research Grade Dinutuximab |
| DHJ64001 | Research Grade Elotuzumab |
| DHJ24002 | Research Grade Evolocumab |
| DHB86901 | Research Grade Necitumumab |
| DHH02209 | Research Grade Nivolumab |
| DHH28802 | Research Grade Secukinumab |
| DHC13602 | Research Grade Mepolizumab |
| DHJ70101 | Research Grade Atezolizumab |
| DHH28801 | Research Grade Ixekizumab |
| DHD16101 | Research Grade Olaratumab |
| DHC13601 | Research Grade Reslizumab |
| DHF86301 | Research Grade Benralizumab |
| DHJ38901 | Research Grade Brodalumab |
| DHD62601 | Research Grade Dupilumab |
| DHJ70102 | Research Grade Durvalumab |
| DHJ63103 | Research Grade Guselkumab |
| DHD38502 | Research Grade Inotuzumab |
| DHC90702 | Research Grade Ocrelizumab |
| DHC36901 | Research Grade Sarilumab |
| DHJ53401 | Research Grade Burosumab |
| DHH02201 | Research Grade Cemiplimab |
| DHB95401 | Research Grade Emapalumab |
| DHH31001 | Research Grade Erenumab |
| DHC22402 | Research Grade Fremanezumab |
| DHC22401 | Research Grade Galcanezumab |
| DHB95901 | Research Grade Ibalizumab |
| DHC04301 | Research Grade Lanadelumab |
| DHE85301 | Research Grade Mogamulizumab |
| DHB90001 | Research Grade Ravulizumab |
| DHE26301 | Research Grade Polatuzumab |
| DHJ63101 | Research Grade Risankizumab |
| DHJ48701 | Research Grade Romosozumab |
| DHD15101 | Research Grade Crizanlizumab |
| DHJ41001 | Research Grade Enfortumab |
| DHC29903 | Research Grade Teprotumumab |
| DHC22403 | Research Grade Eptinezumab |
| DHD80802 | Research Grade Isatuximab |
| DHC43301 | Research Grade Sacituzumab |
| DHD10802 | Research Grade Inebilizumab |
| DHF92401 | Research Grade Belantamab |
| DHD10803 | Research Grade Tafasitamab |
| DHC36904 | Research Grade Satralizumab |
| DVV03606 | Research Grade Atoltivimab |
| DVV03605 | Research Grade Maftivimab |
| DVV03602 | Research Grade Odesivimab |
| DGK07803 | Research Grade Naxitamab |
| DHC09604 | Research Grade Margetuximab |
| DVV03607 | Research Grade Ansuvimab |
| DHJ88801 | Research Grade Evinacumab |
| DHH02205 | Research Grade Dostarlimab |
| DHD10806 | Research Grade Loncastuximab |
| DHG01306 | Research Grade Pelgifatamab |
| DHD58802 | Research Grade Amlitelimab |
| DHJ70115 | Research Grade Garivulimab |
| DHJ70116 | Research Grade Sudubrilimab |
| DHJ92103 | Research Grade Alomfilimab |
| DHC09611 | Research Grade Coprelotamab |
| DHB96301 | Research Grade Bapotulimab |
| DHD48406 | Research Grade Barecetamab |
| DHD17207 | Research Grade Botensilimab |
| DHH02223 | Research Grade Finotonlimab |
| DHH02224 | Research Grade Geptanolimab |
| DHH02225 | Research Grade Penpulimab |
| DHH02226 | Research Grade Pimivalimab |
| DHC27707 | Research Grade Dafsolimab |
| DHF32701 | Research Grade Daxdilimab |
| DHC13603 | Research Grade Depemokimab |
| DHC90718 | Research Grade Divozilimab |
| DHC90719 | Research Grade Zuberitamab |
| DHH72404 | Research Grade Domvanalimab |
| DHH72405 | Research Grade Ociperlimab |
| DHD84003 | Research Grade Ebdarokimab |
| DHJ24009 | Research Grade Ebronucimab |
| DHB74003 | Research Grade Torudokimab |
| DHB74004 | Research Grade Tozorakimab |
| DHE09501 | Research Grade Enibarcimab |
| DHC41801 | Research Grade Grisnilimab |
| DHH18501 | Research Grade Idactamab |
| DHJ72802 | Research Grade Imsidolimab |
| DHJ44201 | Research Grade Latozinemab |
| DHG17603 | Research Grade Lemzoparlimab |
| DHG17604 | Research Grade Letaplimab |
| DHD19401 | Research Grade Lusvertikimab |
| DHF88302 | Research Grade Melrilimab |
| DHE57001 | Research Grade Mibavademab |
| DHA95601 | Research Grade Nadecnemab |
| DXX05301 | Research Grade Omodenbamab |
| DHC06705 | Research Grade Plonmarlimab |
| DHJ48301 | Research Grade Ponsegromab |
| DHB34101 | Research Grade Sibeprenlimab |
| DHD68911 | Research Grade Sotigalimab |
| DHJ28403 | Research Grade Surzebiclimab |
| DVV00308 | Research Grade Tixagevimab |
| DHC21006 | Research Grade Tusamitamab |
| DHD46602 | Research Grade Uliledlimab |
| DHJ45501 | Research Grade Vixarelimab |
| DHA42304 | Research Grade Zansecimab |
| DHF90701 | Research Grade Zilovertamab |
| DHD38507 | Research Grade Anti-Human CD22 (M971) |
| DHD38508 | Research Grade Anti-Human CD22 (M972) |
| DHD46603 | Research Grade Dresbuxelimab |
| DHD46604 | Research Grade Mupadolimab |
| DHH02230 | Research Grade Nofazinlimab |
| DHH02232 | Research Grade Iparomlimab |
| DHH28812 | Research Grade Gumokimab |
| DHH72406 | Research Grade Tamgiblimab |
| DHD72502 | Research Grade Pivekimab |
| DHA94801 | Research Grade Ginisortamab |
| DHJ32901 | Research Grade Galegenimab |
| DHC85104 | Research Grade Ivicentamab |
| DHC65502 | Research Grade Anselamimab |
| DHJ42801 | Research Grade Anumigilimab |
| DHB48101 | Research Grade Sirexatamab |
| DHE43207 | Research Grade Rocatinlimab |
| DHG17606 | Research Grade Ligufalimab |
| DHD62602 | Research Grade Manfidokimab |
| DHF92104 | Research Grade Trinbelimab |
| DHC83101 | Research Grade Barzolvolimab |
| DHF69501 | Research Grade Eblasakimab |
| DVV03903 | Research Grade Mazorelvimab |
| DVV03904 | Research Grade Zamerovimab |
| DVV00311 | Research Grade Amubarvimab |
| DVV00312 | Research Grade Romlusevimab |
| DVV00315 | Research Grade Adintrevimab |
| DVV00317 | Research Grade Anti-SARS-CoV-2 RBD Antibody(S2H97) |
| DVV00318 | Research Grade Anti-SARS-CoV-2 RBD Antibody (S2E12) |
| DVV00319 | Research Grade Bebtelovimab |
| DHC25204 | Research Grade Anti-Human CD115/CSF1R Antibody (LY3022855) |
| DHF92407 | Research Grade Ispectamab |
| DHJ04005 | Research Grade Ifinatamab |
| DHJ04006 | Research Grade Vobramitamab |
| DHH02233 | Research Grade Peresolimab |
| DHH02234 | Research Grade Rosnilimab |
| DHH02235 | Research Grade Zimberelimab |
| DVV11601 | Research Grade Anivovetmab |
| DHC83102 | Research Grade Briquilimab |
| DHG70701 | Research Grade Camoteskimab |
| DHD85405 | Research Grade Frexalimab |
| DHF66401 | Research Grade Golocdacimab |
| DHJ29001 | Research Grade Litifilimab |
| DVV03103 | Research Grade Zinlirvimab |
| DHF90801 | Research Grade Ozuriftamab |
| DHC82406 | Research Grade Posdinemab |
| DHJ48302 | Research Grade Visugromab |
| DHA30605 | Research Grade Apitegromab |
| DHC83402 | Research Grade Theralizumab |
| DHG17607 | Research Grade Anti-Human CD47/MER6 Antibody (CC-90002) |
| DHF64001 | Research Grade Anti-Human SIRPα / γ Antibody (Kwar23) |
| DHB48102 | Research Grade Anti-Human DKK1 Antibody (BHQ880) |
| DHJ21603 | Research Grade Anti-Human CD85d/ILT4 Antibody (JTX-8064-101) |
| DHK16201 | Research Grade Anti-Human CD112R/PVRIG (GSK4381562) |
| DHD50701 | Research Grade Anti-Human IL10 Antibody (BT-063) |
| DHG84901 | Research Grade Anti-Human IL11RA Antibody (X209) |
| DHF11801 | Research Grade Anti-Human CDH6 Antibody (HKT288) |
| DHD50001 | Research Grade Fanolesomab |
| DHG62602 | Research Grade Anti-Human TPBG/5T4 (PF-06263507) |
| DHJ46901 | Research Grade Anti-Human GPA33 (KRN330) |
| DHG53501 | Research Grade Anti-Human ADAM9 (IMGC936) |
| DHG64002 | Research Grade Anti-Human CD166/ALCAM (AT002) |
| DHC12520 | Research Grade Anti-Human APP/Amyloid beta (CNTO 2125) |
| DHC12522 | Research Grade Anti-Human APP/Amyloid beta (DLX212) |
| DHC12523 | Research Grade Anti-Human APP/Amyloid beta (GSK 933776) |
| DHA42307 | Research Grade Anti-Human ANGPT2 (MEDI-3617) |
| DHD89506 | Research Grade Anti-Human AXL/UFO (ORY012) |
| DHJ04007 | Research Grade Anti-Human CD276/B7-H3 (DS-5573a) |
| DHG26701 | Research Grade Anti-Human CD317/BST2 (XmAb 5592) |
| DHJ14402 | Research Grade Anti-Human CD272/BTLA (LY3361237) |
| DHD46202 | Research Grade Anti-Human CNR1/CB1 (GFB-024) |
| DHF69601 | Research Grade Anti-Human CCL20/MIP-3-alpha (GSK3050002) |
| DHJ16303 | Research Grade Anti-Human CD163 (OR2805) |
| DHC90740 | Research Grade Anti-Human CD20/MS4A1 (TRU015) |
| DHC83403 | Research Grade Anti-Human CD28 (FR-104) |
| DHD37508 | Research Grade Anti-Human CD33 (IMGN779) |
| DHC85106 | Research Grade Anti-Human CD37/TSPAN26 (AGS67E) |
| DHE74002 | Research Grade Anti-Human CD39/ENTPD1 (TTX-030) |
| DHE74001 | Research Grade Anti-Human CD39/ENTPD1 (SRF617) |
| DHB95911 | Research Grade Anti-Human CD4 (TRX1) |
| DHC31202 | Research Grade Anti-Human CD98/SLC3A2 (IGN523) |
| DHF11802 | Research Grade Anti-Human CDH6 (DS-6000a) |
| DHE25606 | Research Grade Anti-Human CD66c/CEACAM6 (NEO-201) |
| DHF19201 | Research Grade Anti-Human CLDN6 (IMAB-027) |
| DHC34210 | Research Grade Anti-Human MET/c-Met/HGFR (REGN5093) |
| DHC34212 | Research Grade Anti-Human MET/c-Met/HGFR (SAIT301) |
| DHC01902 | Research Grade Anti-Human CXCL10/IP-10 (NI-0801) |
| DHA91302 | Research Grade Anti-Human CD205/LY75/DEC-205 (CDX-1401) |
| DHA91301 | Research Grade Anti-Human CD205/LY75/DEC-205 (MEN1309) |
| DHF71402 | Research Grade Anti-Human DLK1 (ADCT-701) |
| DHA29110 | Research Grade Anti-Human CD262/TNFRSF10B/TRAIL-R2/DR5 (DS-8273a) |
| DHB86926 | Research Grade Anti-Human EGFR/ERBB1/HER1 (7A7) |
| DHD82401 | Research Grade Anti-Human EPHA2 (MEDI-547) |
| DHF05301 | Research Grade Anti-Human EPHA4 (PF-06647263) |
| DHC93501 | Research Grade Anti-Human CD32/FCGR2A (VIB9600) |
| DHJ61901 | Research Grade Anti-Human FPN1/SLC40A1/Ferroportin (LY2928057) |
| DHB73301 | Research Grade Anti-Human FGF19 (1A6) |
| DHC38201 | Research Grade Anti-Human FGF2/bFGF (HuGAL-F2) |
| DHD52903 | Research Grade Anti-Human CD333/FGFR3 (LY3076226) |
| DHE19103 | Research Grade Anti-Human CD135/FLT3 (IMC-EB10) |
| DHE16501 | Research Grade Anti-Human FLT4 (LY3022856) |
| DVV02813 | Research Grade Anti-RSV F/Fusion glycoprotein F0 (hRSV90) |
| DHB94403 | Research Grade Infliximab |
| DHB94402 | Research Grade Adalimumab |
| DHB86939 | Research Grade Becotatug |
| DHD19402 | Research Grade Bempikibart |
| DHC02003 | Research Grade Delpacibart |
| DHG53502 | Research Grade Izeltabart |
| DHE74005 | Research Grade Perenostobart |
| DHB54001 | Research Grade Tulisokibart |
| DHK27701 | Research Grade Ulviprubart |
| DHD30402 | Research Grade Favezelimab |
| DHC09601 | Research Grade Trastuzumab |
| DHD41001 | Research Grade Efalizumab |
| DHB95803 | Research Grade Camidanlumab |
| DHG17601 | Research Grade Magrolimab |
| DHD17206 | Research Grade Quavonlimab |
| DHC29901 | Research Grade Dalotuzumab |
| DHC29906 | Research Grade Robatumumab |
| DHD17402 | Research Grade Adecatumumab |
| DHB86906 | Research Grade Matuzumab |
| DHH72403 | Research Grade Vibostolimab |
| DGK07802 | Research Grade Lorukafusp Alfa |
| DGK11302 | Research Grade Mitumomab |
| DXX00201 | Research Grade Actoxumab |
| DHJ17801 | Research Grade Anti-Human KLB/Beta-klotho Antibody (MK-3655) |
| DHC29908 | Research Grade Lonigutamab |
| DHB86902 | Research Grade Cetuximab |
| DHH02202 | Research Grade Pembrolizumab |
| DHJ70103 | Research Grade Avelumab |
| DHJ63102 | Research Grade Tildrakizumab |
| DVV02808 | Research Grade Clesrovimab |
| DHD00201 | Research Grade Anti-Human CD66a/CEACAM1 (CM-24) |
| DHG70702 | Research Grade Anti-Human IL18/IL1F4 (ABT-325) |
| DHE28303 | Research Grade Anti-Human IL15 (DISC0280) |
| DVV03104 | Research Grade Teropavimab |
| DHD51901 | Research Grade Anti-Human CD334/FGFR4 (U3-1784) |
| DHB87401 | Research Grade Ichorcumab |
| DHK16101 | Research Grade Lirentelimab |
| DHD15501 | Research Grade Leukotuximab |
| DHG76501 | Research Grade Neihulizumab |
| DVV04301 | Research Grade Arevirumab-3 |
| DVV00502 | Research Grade Anti-SARS-CoV-2 S2 Protein (CV3-25) |
| DHH55901 | Research Grade Anti-Human GFRAL (NGM120) |
| DHK27901 | Research Grade Anti-Human SLC2A8GLUT8 (VB1-050) |
| DHK28001 | Research Grade Anti-Human GPR20 (DS-6157a) |
| DHJ42901 | Research Grade Anti-Human HBEGF (KHK2866) |
| DHJ11401 | Research Grade Anti-Human HJV/Hemojuvelin (DISC-0974) |
| DHF71901 | Research Grade Anti-Human HAMP/Hepcidin (LY2787106) |
| DHD03704 | Research Grade Anti-Human HGF (TAK-701) |
| DHC08003 | Research Grade Anti-Human HLA-DR (IMMU-114) |
| DHJ92106 | Research Grade Anti-Human CD278/ICOS (MEDI-570) |
| DHB95403 | Research Grade Anti-Human IFNG/IFN-gamma (AMG 811) |
| DHB94101 | Research Grade Anti-Human IGF2 (DX-2647) |
| DHE07709 | Research Grade Anti-Human IL13 (H2L6) |
| DHE07710 | Research Grade Anti-Human IL13 (M1295) |
| DHE07711 | Research Grade Anti-Human IL13 (CNTO 607) |
| DHE07713 | Research Grade Anti-Human IL13 (GSK679586) |
| DHE07715 | Research Grade Anti-Human IL13 (IMA-026) |
| DHH28814 | Research Grade Anti-Human IL17A (CAT-2200) |
| DHG70704 | Research Grade Anti-Human IL18/IL1F4 (GSK 1070806) |
| DHB95606 | Research Grade Anti-Human IL1B/IL1F2 (CDP484) |
| DHJ63107 | Research Grade Anti-Human IL23A/IL-23p19 (LY2525623) |
| DHD72508 | Research Grade Anti-Human CD123/IL3RA (SGN-CD123A) |
| DHD62610 | Research Grade Anti-Human CD124/IL4R/IL-4Rα (MEDI2045) |
| DHD29901 | Research Grade Anti-Human ITGB6 (SGN-B6A) |
| DHK27602 | Research Grade Anti-Human KAAG1 (ADCT-901) |
| DHC83106 | Research Grade Anti-Human CD117/KIT (LOP628) |
| DHC87701 | Research Grade Anti-Human CD107a/LAMP1 (SAR428926) |
| DHB21801 | Research Grade Anti-Human LGR5 (BNC101) |
| DHD08001 | Research Grade Anti-Human LIF (MSC-1) |
| DHC33401 | Research Grade Anti-LPA/Lysophosphatidic acid Antibody (LT3015) |
| DHG52004 | Research Grade Anti-Human MSLN/Mesothelin (BMS 986148) |
| DHB91705 | Research Grade Anti-Human NGF/Beta-NGF (AS2886401-00) |
| DHB91707 | Research Grade Anti-Human NGF/Beta-NGF (MEDI-578) |
| DHC81101 | Research Grade Anti-Human OPN/SPP1 (ASK8007) |
| DHE43210 | Research Grade Anti-Human CD134/TNFRSF4/OX40 (BMS 986178) |
| DHD50504 | Research Grade Anti-Human CDH3/P-cadherin (PF-03732010) |
| DHJ24014 | Research Grade Anti-Human PCSK9 (RG7652) |
| DHB91201 | Research Grade Anti-Human PDGFB (MOR-8457) |
| DHC42203 | Research Grade Anti-Human CD140b/PDGFRB (IMC-2C5) |
| DHD18003 | Research Grade Anti-Human PRLR (BAY 1158061) |
| DHC97901 | Research Grade Anti-Human CCL5/RANTES (NI-0701) |
| DHD71001 | Research Grade Anti-Human S100A4 (LK-1) |
| DHK13702 | Research Grade Anti-Human SIGLEC15/CD33L3 (AB-25E9) |
| DHK13705 | Research Grade Anti-Human SIGLEC15/CD33L3 (NC318) |
| DHJ64004 | Research Grade Anti-Human CD319/SLAMF7 (PDL241) |
| DHC82407 | Research Grade Anti-Human MAPT/Tau/PHF-tau (APNmAb005) |
| DHD00602 | Research Grade Anti-Human CD142/F3/TF (TNX-832) |
| DHB91609 | Research Grade Anti-Human TGFB1/TGF-beta-1 (SRK-181) |
| DHA53402 | Research Grade Anti-Human CD283/TLR3 (CNTO5429) |
| DHB94415 | Research Grade Anti-Human TNFa/TNF-alpha (ESBA 105) |
| DHB94427 | Research Grade Anti-Human TNFa/TNF-alpha (CMAB008) |
| DHJ62501 | Research Grade Anti-Human CD354/TREM1 (PY159) |
| DHE70301 | Research Grade Anti-Human VEGFB (CSL 346) |
| DHE70401 | Research Grade Anti-Human VEGFC (VGX100) |
| DHE16607 | Research Grade Anti-Human CD309/KDR/VEGFR-2 (ImClone 6.64) |
| DHK11102 | Research Grade Anti-Human Lewis Y (MB 311) |
| DHC09801 | Research Grade Anti-Human NTRK1/TRKA (GBR 900) |
| DGK80501 | Research Grade Sonepcizumab |
| DVV00345 | Research Grade Anti-SARS-CoV-2 RBD Antibody (BD55-5514) |
| DHJ69203 | Research Grade Anti-Human TERM2 Antibody (PY314) |
| DHB95813 | Research Grade Vopikitug |
| DHC34218 | Research Grade Davutamig |
| DHB54007 | Research Grade Duvakitug |
| DHH02241 | Research Grade Enlonstobart |
| DHC19106 | Research Grade Ersodetug |
| DHD17226 | Research Grade Gotistobart |
| DHE58701 | Research Grade Maridebart |
| DHA91304 | Research Grade Oberotatug |
| DHD27101 | Research Grade Oloctinebart |
| DHD65901 | Research Grade Patecibart |
| DHD62613 | Research Grade Rademikibart |
| DHD62614 | Research Grade Stapokibart |
| DHK08201 | Research Grade Sabirnetug |
| DHJ22703 | Research Grade Temtokibart |
| DHJ28413 | Research Grade Verzistobart |
| DHJ14404 | Research Grade Anti-Human CD272/BTLA Antibody (22B3) |
| DHJ22704 | Research Grade Anti-Human IL22RA1 Antibody (ARGX-112) |
| DHH86501 | Research Grade Anti-Human SEZ6 Antibody (ABBV-011) |
| DHC90744 | Research Grade Rituximab |
| DHD68932 | Research Grade Abiprubart |
| DHG33801 | Research Grade Rezorstobart |
| DHK86201 | Research Grade Seniprutug |
| DHD29902 | Research Grade Sigvotatug |
| DVV00353 | Research Grade Sipavibart |
| DHJ36107 | Research Grade Solrikitug |
| DHJ27904 | Research Grade Ucenprubart |
| DHJ14405 | Research Grade Venanprubart |
| DHK27201 | Research Grade Verekitug |
| DHD34001 | Research Grade Atrosimab |
| DVV03006 | Research Grade Anti-HBsAg Reference Antibody (OST 577) |
| DHE22009 | Research Grade Amlenetug |
| DHJ36109 | Research Grade Bosakitug |
| DHG52009 | Research Grade Misitatug |
| DHB88501 | Research Grade Ruxoprubart |
| DHK28702 | Research Grade Anti-Human Fucosyl-GM1 Antibody (BMS-986012) |
| DHG02802 | Research Grade Anti-Human ACVR1/ALK-2 Antibody (DS-6016a) |
| DHD72805 | Research Grade Anti-Human ACVR2A Antibody (Ab-14E1) |
| DHJ17803 | Research Grade Anti-Human KLB/Beta-klotho Antibody (RG7992) |
| DHD67801 | Research Grade Anti-Human CTSS/Cathepsin S Antibody (Fsn0503h) |
| DHC97902 | Research Grade Anti-Human CCL5/RANTES Antibody (VLST-002) |
| DHD11901 | Research Grade Anti-Human CD46 Antibody (FOR46) |
| DHN05401 | Research Grade Anti-Human DCBLD2CLCP1 Antibody (FA19-1) |
| DHC00807 | Research Grade Anti-Human Fibronectin Antibody (L19-TNF) |
| DHC81801 | Research Grade Anti-Human LAP (TGFB3) Antibody (Brigham and Womens anti-LAP) |
| DHG31501 | Research Grade Anti-Human MERTK/MER Antibody (RGX-019) |
| DHG08901 | Research Grade Anti-Human TYRO3/DTK/SYK Antibody (ELB031) |
| DHC34302 | Research Grade Anti-Human CD228/MELTF Antibody (SC-005) |
| DHC20402 | Research Grade Anti-Human Complement C2 Antibody (ARGX-117) |
| DHB89904 | Research Grade Anti-Human Complement C3 Antibody (NGM621) |
| DHC84102 | Research Grade Anti-Human CLU/APOJ/Clusterin Antibody (AB-16B5) |
| DHC17601 | Research Grade Anti-Human CD29/ITGB1 Antibody (OS2966) |
| DHK80401 | Research Grade Anti-ChoPPhosphorylcholine Antibody (ATH3G10) |
| DHF69502 | Research Grade Anti-Human CD213a1/IL13RA1 Antibody (MK-6105) |
| DHE26201 | Research Grade Anti-Human CD110/MPL Antibody (TA136) |
| DHH22301 | Research Grade Anti-Human SCN9A/Nav1.7 Antibody (Duke anti-NAv1.7) |
| DHJ49901 | Research Grade Anti-Human RG1/Mindin Antibody (19G9) |
| DHF71403 | Research Grade Anti-Human DLK1 Antibody (LIV-1205) |
| DHJ71701 | Research Grade Anti-Human CD315/PTGFRN Antibody (AG02-ADC) |
| DHD63001 | Research Grade Anti-Human EDNRB/ETRB Antibody (DEDN6526A) |
| DHC83108 | Research Grade Anti-Human CD117/KIT Antibody (CDX-0158) |
| DHD37701 | Research Grade Anti-Human KLK2 Antibody (JNJ-69086420) |
| DHH45205 | Research Grade Anti-Human MICA Antibody (CLN-619) |
| DHF09501 | Research Grade Anti-Human F2RL1/PAR-2 Antibody (PAR650097) |
| DHF12001 | Research Grade Anti-Human CDH11 Antibody (RG6125) |
| DHG03403 | Research Grade Anti-Human CD136/MST1R Antibody (Aveo anti-RON) |
| DHF19601 | Research Grade Anti-Human BACE1 Antibody (Genentech anti-BACE1) |
| DHJ24019 | Research Grade Anti-Human PCSK9 Antibody (Boehringer anti-PCSK9) |
| DHD68933 | Research Grade Anti-Human CD40/TNFRSF5 Antibody (Emory U. anti-CD40) |
| DHE55401 | Research Grade Anti-Human CXCL12/SDF-1 Antibody (Genentech anti-CXCL12) |
| DHB86949 | Research Grade Anti-Human EGFR/ERBB1/HER1 Antibody (Duke D2C7) |
| DHD10833 | Research Grade Anti-Human CD19 Antibody (Immunomedics hA19) |
| DHG15801 | Research Grade Anti-Human CD167a/DDR1 Antibody (Imperial College anti-DDR1) |
| DHF71903 | Research Grade Anti-Human HAMP/Hepcidin Antibody (Ludwig-Maximilians U. anti_Hepsin) |
| DHC12526 | Research Grade Anti-Human APP/Amyloid beta Antibody (Merck anti-Amyloid beta 19.3) |
| DHC15819 | Research Grade Anti-Human IL6/IFNb2 Antibody (MEDI 5117) |
| DHC36909 | Research Grade Anti-Human CD126/IL6R/IL-6RA Antibody (APX007) |
| DHD19406 | Research Grade Anti-Human CD127/IL7R Antibody (PF-06342674) |
| DHA69202 | Research Grade Anti-Human CD255/TNFSF12/TWEAK Antibody (RO5458640/RG7212) |
| DHF92105 | Research Grade Anti-Human CD240D/RHD Antibody (LFB Anti-RhD) |
| DHK06703 | Research Grade Anti-Human Reticulon-4/RTN4 Antibody (NG-101) |
| DHE21001 | Research Grade Anti-Human TGFBR2/TGFR-2 Antibody (LY3022859) |
| DHK10202 | Research Grade Anti-Human TCR Antibody (NKTT320) |
| DHB91610 | Research Grade Anti-Human TGFB1/TGF-beta-1 Antibody (NIS793) |
| DHK10201 | Research Grade Anti-Human TCR Antibody (TOL101) |
| DHB94440 | Research Grade Anti-Human TNFa/TNF-alpha Antibody (hMAK195) |
| DHE16610 | Research Grade Anti-Human CD309/KDR/VEGFR-2 Antibody (AT001) |
| DHD82101 | Research Grade Anti-Human A2AR/ADORA2A Antibody (3F6-9G5) |
| DHG51602 | Research Grade Anti-Human BTN1A1 Antibody (ICT-01) |
| DHF64013 | Research Grade Anti-Human CD172a/SIRPA Antibody (BI 765063) |
| DHG31402 | Research Grade Anti-Human CDH17/Cadherin-17 Antibody (PTA001_A4) |
| DHF19205 | Research Grade Anti-Human CLDN6 Antibody (DS-9606a) |
| DHF19206 | Research Grade Anti-Human CLDN6 Antibody (AE3-20) |
| DHF19207 | Research Grade Anti-Human CLDN6 Antibody (64A) |
| DHF19209 | Research Grade Anti-Human CLDN6 Antibody (AB1-11) |
| DHG03402 | Research Grade Anti-Human CD136/MST1R Antibody (H5B14) |
| DHJ57503 | Research Grade Anti-Human CD318/CDCP1 Antibody (38 E11#) |
| DHJ63901 | Research Grade Anti-Human CD93/C1qR Antibody (Dcby02) |
| DHE43301 | Research Grade Anti-Human NAMPT Antibody (Alt-100) |
| DHG84903 | Research Grade Anti-Human IL11RA Antibody (LASN 01) |
| DHC33402 | Research Grade Lpathomab |
| DGK80502 | Research Grade Sphingomab |
비밀번호 확인